Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    TopAbstracts in Hypertension 11/26/2008 - (DGNews)
    Potassium Loss Caused by Thiazides May Explain Higher Risk of Adult Diabetes - (DGNews)
    High Blood Pressure in Doctor's Office May Not Predict Heart Risks - (DGNews)
    TopAbstracts in Hypertension 11/19/2008 - (DGNews)
    Aliskiren Helps Elderly Patients Achieves Blood Pressure Control: Presented at AHA - (DGDispatch)

    News archive

     Recent webcasts/CME - Hypertension
    • Minimizing Cardiovascular Risk in Patients With Dyslipidemia
    • Beta-Blockers in Hypertension - The Con Discussion
      Vaccination: A New Approach to RAAS Inhibition?
      Beta-Blockers in Hypertension - The Pro Discussion
      Which Anti-RAAS Shall We Use?

      Webcasts/CME archive

       Recent cases - Hypertension
        Aortic Dissection Type I in a Weightlifter with Hypertension: A Case Report
        Transient Left Ventricular Apical Ballooning and Exercise Induced Hypertension During Treadmill Exercise Testing: Is There a Common Hypersympathetic Mechanism?
        Dilation of Renal Artery Stenosis after Administration of Losartan
        Angioedema of the Tongue
        Primary Aldosteronism Caused by a Unilateral Adrenal Adenoma Accompanied by Autonomous Cortisol Secretion

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Lercandipine Effective in Treating Hypertension in Patients With Chronic Kidney Failure: Presented at ASH(HYP)

        By Ed Susman

        NEW YORK, NY -- May 21, 2003 -- The new calcium channel blocker lercandipine is effective in treating patients with high blood pressure (BP) who are also experiencing chronic renal failure, researchers reported on May 15th here at the 18th Annual Scientific Meeting of the American Society of Hypertension.

        Joan Ocom, MD, chief of the hypertension unit, Fundacion Puigvert, Barcelona, Spain, said patients treated with lercandipine, which is approved for use in Europe, also showed improvement in kidney function, with a decrease in proteinuria from 3.5 g at baseline to 2.8 g at the end of the 6-month trial (P=0.015).

        "Lercandipine has a good tolerability profile, and showed an interesting effect on plasmatic lipids, " he said at his poster presentation.

        Dr. Ocom recruited 175 patients to the study. The average age was 63; 52.9% were men. Almost 90% of patients showed an improvement in BP, and 58% of patients achieved a BP reduction to a goal of less than 130/85 mm Hg.

        The study was designed to determine whether lercandipine would be helpful in patients who have salt retention and edema. "A large part of the calcium channel blockers are eliminated through the liver, and require only a small dose adjustment in [patients with] chronic renal failure," Dr. Ocom noted.

        Audience members raised questions about whether lercandipine would affect other factors in renal failure, but, he said, "an improvement in renal function, measured through creatinine clearance, was detected."

        Seventy-eight percent of patients treated with lercandipine achieved at least a 10/10 mm Hg decrease in BP; 82% achieved a 10/5 mm Hg reduction in BP.

        This study was sponsored by Recordati S.p.A. of Milan, Italy.


        [Study title: Lercandipine in Chronic Renal Failure (CRF). Abstract P-168]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send